Myriad Genetics, Inc.
MYGN · Healthcare · $415M
$4.31+1.89%
Price
$6.00
$4.23
Jul 1, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$196M+2.6%
6/'26 vs prev quarter
Company Health
Market Cap$415M
Operating Margin-11.6%
Cash on Hand$115M27.8% of market cap
Free Cash Flow$-1M-0.3% of market cap
Among 39 Medical - Diagnostics & Research peers
LowMedianHigh
PSR0.5xmedian 5.4xPBR1.3xmedian 2.9xROE-37.0%median -3.0%
